These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32172165)

  • 81. Preparation and characterization of decyl-terminated silicon nanoparticles encapsulated in lipid nanocapsules.
    Pan GH; Barras A; Boussekey L; Qu X; Addad A; Boukherroub R
    Langmuir; 2013 Oct; 29(41):12688-96. PubMed ID: 24083658
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Highly luminescent and nontoxic amine-capped nanoparticles from porous silicon: synthesis and their use in biomedical imaging.
    Ahire JH; Wang Q; Coxon PR; Malhotra G; Brydson R; Chen R; Chao Y
    ACS Appl Mater Interfaces; 2012 Jun; 4(6):3285-92. PubMed ID: 22624976
    [TBL] [Abstract][Full Text] [Related]  

  • 83. In vitro assessment of biopolymer-modified porous silicon microparticles for wound healing applications.
    Mori M; Almeida PV; Cola M; Anselmi G; Mäkilä E; Correia A; Salonen J; Hirvonen J; Caramella C; Santos HA
    Eur J Pharm Biopharm; 2014 Nov; 88(3):635-42. PubMed ID: 25305585
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Cellular interactions of surface modified nanoporous silicon particles.
    Bimbo LM; Sarparanta M; Mäkilä E; Laaksonen T; Laaksonen P; Salonen J; Linder MB; Hirvonen J; Airaksinen AJ; Santos HA
    Nanoscale; 2012 May; 4(10):3184-92. PubMed ID: 22508528
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Mesoporous silicon in drug delivery applications.
    Salonen J; Kaukonen AM; Hirvonen J; Lehto VP
    J Pharm Sci; 2008 Feb; 97(2):632-53. PubMed ID: 17546667
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Manipulating human dendritic cell phenotype and function with targeted porous silicon nanoparticles.
    Stead SO; McInnes SJP; Kireta S; Rose PD; Jesudason S; Rojas-Canales D; Warther D; Cunin F; Durand JO; Drogemuller CJ; Carroll RP; Coates PT; Voelcker NH
    Biomaterials; 2018 Feb; 155():92-102. PubMed ID: 29175084
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Controlled drug delivery from composites of nanostructured porous silicon and poly(L-lactide).
    McInnes SJ; Irani Y; Williams KA; Voelcker NH
    Nanomedicine (Lond); 2012 Jul; 7(7):995-1016. PubMed ID: 22394185
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Gold nanoparticles modified porous silicon chip for SALDI-MS determination of glutathione in cells.
    Wang J; Jie M; Li H; Lin L; He Z; Wang S; Lin JM
    Talanta; 2017 Jun; 168():222-229. PubMed ID: 28391846
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Multifunctional Nanohybrid Based on Porous Silicon Nanoparticles, Gold Nanoparticles, and Acetalated Dextran for Liver Regeneration and Acute Liver Failure Theranostics.
    Liu Z; Li Y; Li W; Xiao C; Liu D; Dong C; Zhang M; Mäkilä E; Kemell M; Salonen J; Hirvonen JT; Zhang H; Zhou D; Deng X; Santos HA
    Adv Mater; 2018 Jun; 30(24):e1703393. PubMed ID: 29024054
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Surface chemistry and pore size affect carrier properties of mesoporous silicon microparticles.
    Limnell T; Riikonen J; Salonen J; Kaukonen AM; Laitinen L; Hirvonen J; Lehto VP
    Int J Pharm; 2007 Oct; 343(1-2):141-7. PubMed ID: 17600644
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Estimating attachment of nano- and submicrometer-particles coated with organic macromolecules in porous media: development of an empirical model.
    Phenrat T; Song JE; Cisneros CM; Schoenfelder DP; Tilton RD; Lowry GV
    Environ Sci Technol; 2010 Jun; 44(12):4531-8. PubMed ID: 20465214
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epithelium.
    Araújo F; Shrestha N; Shahbazi MA; Fonte P; Mäkilä EM; Salonen JJ; Hirvonen JT; Granja PL; Santos HA; Sarmento B
    Biomaterials; 2014 Nov; 35(33):9199-207. PubMed ID: 25109441
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Macroporous silicon templated from silicon nanocrystallite and functionalized Si-H reactive group for grafting organic monolayer.
    Guo DJ; Wang J; Tan W; Xiao SJ; Dai ZD
    J Colloid Interface Sci; 2009 Aug; 336(2):723-9. PubMed ID: 19446831
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Self-Sealing Porous Silicon-Calcium Silicate Core-Shell Nanoparticles for Targeted siRNA Delivery to the Injured Brain.
    Kang J; Joo J; Kwon EJ; Skalak M; Hussain S; She ZG; Ruoslahti E; Bhatia SN; Sailor MJ
    Adv Mater; 2016 Sep; 28(36):7962-7969. PubMed ID: 27383373
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Relevance of Electrostatics for the Interaction of Tyrosine Hydroxylase with Porous Silicon Nanoparticles.
    Bezem MT; Johannessen FG; Kråkenes TA; Sailor MJ; Martinez A
    Mol Pharm; 2021 Mar; 18(3):976-985. PubMed ID: 33417459
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Oxidized Porous Silicon Nanoparticles Covalent-Bonded with Levofloxacin in Hydrogel Polymer as a Drug Delivery System.
    Kim H; Sohn H
    J Nanosci Nanotechnol; 2020 Aug; 20(8):4619-4623. PubMed ID: 32126628
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Label-free optical detection of peptide synthesis on a porous silicon scaffold/sensor.
    Furbert P; Lu C; Winograd N; DeLouise L
    Langmuir; 2008 Mar; 24(6):2908-15. PubMed ID: 18247639
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Tailoring Porous Silicon for Biomedical Applications: From Drug Delivery to Cancer Immunotherapy.
    Li W; Liu Z; Fontana F; Ding Y; Liu D; Hirvonen JT; Santos HA
    Adv Mater; 2018 Jun; 30(24):e1703740. PubMed ID: 29534311
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Multistaged Nanovaccines Based on Porous Silicon@Acetalated Dextran@Cancer Cell Membrane for Cancer Immunotherapy.
    Fontana F; Shahbazi MA; Liu D; Zhang H; Mäkilä E; Salonen J; Hirvonen JT; Santos HA
    Adv Mater; 2017 Feb; 29(7):. PubMed ID: 28009461
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Engineering multi-stage nanovectors for controlled degradation and tunable release kinetics.
    Martinez JO; Chiappini C; Ziemys A; Faust AM; Kojic M; Liu X; Ferrari M; Tasciotti E
    Biomaterials; 2013 Nov; 34(33):8469-77. PubMed ID: 23911070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.